Medical Developments International Ltd (MVP) - Total Assets
Based on the latest financial reports, Medical Developments International Ltd (MVP) holds total assets worth AU$66.40 Million AUD (≈ $46.98 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medical Developments International Ltd - Total Assets Trend (2003–2025)
This chart illustrates how Medical Developments International Ltd's total assets have evolved over time, based on quarterly financial data. Also see MVP stock market capitalisation for the company's overall valuation and market capitalisation.
Medical Developments International Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Medical Developments International Ltd's total assets of AU$66.40 Million consist of 53.5% current assets and 46.5% non-current assets. Review MVP total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$17.84 Million | 26.9% |
| Accounts Receivable | AU$7.51 Million | 11.3% |
| Inventory | AU$9.45 Million | 14.2% |
| Property, Plant & Equipment | AU$8.94 Million | 13.5% |
| Intangible Assets | AU$2.06 Million | 3.1% |
| Goodwill | AU$3.81 Million | 5.7% |
Asset Composition Trend (2003–2025)
This chart illustrates how Medical Developments International Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See MVP stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medical Developments International Ltd's current assets represent 53.5% of total assets in 2025, an increase from 25.0% in 2003.
- Cash Position: Cash and equivalents constituted 26.9% of total assets in 2025, up from 8.4% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 61.0% in 2003.
- Asset Diversification: The largest asset category is cash and equivalents at 26.9% of total assets.
Medical Developments International Ltd Competitors by Total Assets
Key competitors of Medical Developments International Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Medical Developments International Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.54 | 2.74 | 3.16 |
| Quick Ratio | 3.33 | 1.82 | 2.44 |
| Cash Ratio | 2.28 | 1.02 | 1.89 |
| Working Capital | AU$27.72 Million | AU$16.59 Million | AU$17.74 Million |
Medical Developments International Ltd - Advanced Valuation Insights
This section examines the relationship between Medical Developments International Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.12 |
| Latest Market Cap to Assets Ratio | 0.58 |
| Asset Growth Rate (YoY) | 12.2% |
| Total Assets | AU$66.40 Million |
| Market Capitalization | $38.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medical Developments International Ltd's assets below their book value (0.58x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medical Developments International Ltd's assets grew by 12.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medical Developments International Ltd (2003–2025)
The table below shows the annual total assets of Medical Developments International Ltd from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$66.40 Million ≈ $46.98 Million |
+12.23% |
| 2024-06-30 | AU$59.16 Million ≈ $41.86 Million |
-45.96% |
| 2023-06-30 | AU$109.49 Million ≈ $77.47 Million |
+8.02% |
| 2022-06-30 | AU$101.36 Million ≈ $71.72 Million |
+1.18% |
| 2021-06-30 | AU$100.17 Million ≈ $70.88 Million |
+5.61% |
| 2020-06-30 | AU$94.85 Million ≈ $67.11 Million |
+11.85% |
| 2019-06-30 | AU$84.80 Million ≈ $60.00 Million |
+71.15% |
| 2018-06-30 | AU$49.55 Million ≈ $35.06 Million |
+18.64% |
| 2017-06-30 | AU$41.76 Million ≈ $29.55 Million |
+1.27% |
| 2016-06-30 | AU$41.24 Million ≈ $29.18 Million |
+79.39% |
| 2015-06-30 | AU$22.99 Million ≈ $16.27 Million |
+1.90% |
| 2014-06-30 | AU$22.56 Million ≈ $15.96 Million |
+11.25% |
| 2013-06-30 | AU$20.28 Million ≈ $14.35 Million |
+5.97% |
| 2012-06-30 | AU$19.14 Million ≈ $13.54 Million |
+14.50% |
| 2011-06-30 | AU$16.71 Million ≈ $11.83 Million |
+17.57% |
| 2010-06-30 | AU$14.21 Million ≈ $10.06 Million |
+6.15% |
| 2009-06-30 | AU$13.39 Million ≈ $9.48 Million |
+1.54% |
| 2008-06-30 | AU$13.19 Million ≈ $9.33 Million |
+8.87% |
| 2007-06-30 | AU$12.12 Million ≈ $8.57 Million |
-3.07% |
| 2006-06-30 | AU$12.50 Million ≈ $8.84 Million |
+8.17% |
| 2005-06-30 | AU$11.55 Million ≈ $8.18 Million |
-7.35% |
| 2004-06-30 | AU$12.47 Million ≈ $8.82 Million |
+7.21% |
| 2003-06-30 | AU$11.63 Million ≈ $8.23 Million |
-- |
About Medical Developments International Ltd
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more